Patents by Inventor Myra Gilligan

Myra Gilligan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arylsulfonylnaphthalene derivatives as 5HTantagonists
    Patent number: 7592456
    Abstract: Compounds of formula (I) are potent and selective 5-HT2A antagonists, useful in treatment of a variety of adverse conditions of the CNS.
    Type: Grant
    Filed: November 28, 2005
    Date of Patent: September 22, 2009
    Assignee: Merck Sharp & Dohme Limited
    Inventors: Mark Stuart Chambers, Neil Roy Curtis, Emanuela Gancia, Myra Gilligan, Alexander Charles Humphries, Tamara Ladduwahetty, Robert James Maxey, Kevin John Merchant
  • Diarylsulfones as 5-HT2A Antagonists
    Publication number: 20090170824
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: December 12, 2008
    Publication date: July 2, 2009
    Inventors: Jose Luis Castro Pineiro, Laura Catherine Cooper, Myra Gilligan, Alexander Charles Humphries, Peter Alen Hunt, Tamara Ladduwahetty, Angus Murray MacLeod, Kevin John Merchant, Monique Bodil Van Niel, Kevin Wilson
  • Diarylsulfones as 5-HT2A antagonists
    Patent number: 7468393
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: December 23, 2008
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Jose Luis Castro Pineiro, Laura Catherine Cooper, Myra Gilligan, Alexander Charles Humphries, Peter Alan Hunt, Tamara Ladduwahetty, Angus Murray MacLeod, Kevin John Merchant, Monique Bodil Van Niel, Kevin Wilson
  • Heteroarylsulfonyl Stilbenes as 5-Ht2a Antagonists
    Publication number: 20080280956
    Abstract: Compounds of formula I: are potent and selective antagonists of the 5-HT2A receptor, and hence are useful in treatment of various 10 CNS disorders.
    Type: Application
    Filed: March 2, 2006
    Publication date: November 13, 2008
    Inventors: Myra Gilligan, Alexander Charles Humphries, Tamara Ladduwahetty, Kevin John Merchant
  • Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
    Publication number: 20070281952
    Abstract: Compounds of formula (I) are potent and selective 5-HT2A antagonists, useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: November 28, 2005
    Publication date: December 6, 2007
    Inventors: Mark Chambers, Neil Curtis, Emanuela Gancia, Myra Gilligan, Alexander Humphries, Tamara Ladduwahetty, Robert Maxey, Kevin Merchant
  • Diarylsulfones as 5-HT2A antagonists
    Publication number: 20070203205
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: April 27, 2007
    Publication date: August 30, 2007
    Inventors: Jose Castro Pineiro, Laura Cooper, Myra Gilligan, Alexander Humphries, Peter Hunt, Tamara Ladduwahetty, Angus MacLeod, Kevin Merchant, Monique Van Niel, Kevin Wilson
  • Diarylsulfones as 5-HT2A antagonists
    Patent number: 7217740
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Grant
    Filed: August 26, 2005
    Date of Patent: May 15, 2007
    Assignee: Merck Sharp and Dohme
    Inventors: Jose Luis Castro Pineiro, Laura Catherine Cooper, Myra Gilligan, Alexander Charles Humphries, Peter Alan Hunt, Tamara Ladduwahetty, Angus Murray MacLeod, Kevin John Merchant, Monique Bodil Van Niel, Kevin Wilson
  • 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor
    Publication number: 20060211735
    Abstract: Compounds of formula (I): are selective antagonists of the 5-HT2A receptor, and hence are useful in treatment of adverse conditions at the central nervous system, such as sleep disorders and schizophrenia.
    Type: Application
    Filed: May 7, 2004
    Publication date: September 21, 2006
    Inventors: Myra Gilligan, Alexander Humphries, Tamara Ladduwahetty
  • Diarylsulfones as 5-HT2A antagonists
    Publication number: 20060052445
    Abstract: Compounds of formula I: are potent and selective antagonists of the human 5-HT2A receptor, and hence useful in treatment of a variety of adverse conditions of the CNS.
    Type: Application
    Filed: August 26, 2005
    Publication date: March 9, 2006
    Inventors: Jose Castro Pineiro, Laura Cooper, Myra Gilligan, Alexander Humphries, Peter Hunt, Tamara Ladduwahetty, Angus MacLeod, Kevin Merchant, Monique Van Niel, Kevin Wilson